BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25048682)

  • 1. Analgesic tolerance to morphine is regulated by PPARγ.
    de Guglielmo G; Kallupi M; Scuppa G; Stopponi S; Demopulos G; Gaitanaris G; Ciccocioppo R
    Br J Pharmacol; 2014 Dec; 171(23):5407-16. PubMed ID: 25048682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone prevents morphine antinociception tolerance and withdrawal symptoms in rats.
    Ghavimi H; Hassanzadeh K; Maleki-Dizaji N; Azarfardian A; Ghasami S; Zolali E; Charkhpour M
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Sep; 387(9):811-21. PubMed ID: 24899385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of a PPARγ-mediated mechanism in the ability of Withania somnifera to attenuate tolerance to the antinociceptive effects of morphine.
    Caputi FF; Rullo L; Acquas E; Ciccocioppo R; Candeletti S; Romualdi P
    Pharmacol Res; 2019 Jan; 139():422-430. PubMed ID: 30503841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone prevents morphine antinociceptive tolerance via ameliorating neuroinflammation in rat cerebral cortex.
    Ghavimi H; Charkhpour M; Ghasemi S; Mesgari M; Hamishehkar H; Hassanzadeh K; Arami S; Hassanzadeh K
    Pharmacol Rep; 2015 Feb; 67(1):78-84. PubMed ID: 25560579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.
    Elhabazi K; Trigo JM; Mollereau C; Moulédous L; Zajac JM; Bihel F; Schmitt M; Bourguignon JJ; Meziane H; Petit-demoulière B; Bockel F; Maldonado R; Simonin F
    Br J Pharmacol; 2012 Jan; 165(2):424-35. PubMed ID: 21718302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of opioid analgesic tolerance in p75 neurotrophin receptor null mutant mice.
    Trang T; Koblic P; Kawaja M; Jhamandas K
    Neurosci Lett; 2009 Feb; 451(1):69-73. PubMed ID: 19114089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic glutamate receptor 5 signalling induced NMDA receptor subunits alterations during the development of morphine-induced antinociceptive tolerance in mouse cortex.
    Huang M; Luo L; Zhang Y; Wang W; Dong J; Du W; Jiang W; Xu T
    Biomed Pharmacother; 2019 Feb; 110():717-726. PubMed ID: 30553198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice.
    Bohn LM; Lefkowitz RJ; Caron MG
    J Neurosci; 2002 Dec; 22(23):10494-500. PubMed ID: 12451149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent bullatine A enhances morphine antinociception and inhibits morphine antinociceptive tolerance by indirect activation of spinal κ-opioid receptors.
    Huang Q; Sun ML; Chen Y; Li XY; Wang YX
    J Ethnopharmacol; 2017 Jan; 196():151-159. PubMed ID: 27989510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological evidence for systemic and peripheral antinociceptive activities of pioglitazone in the rat formalin test: Role of PPARγ and nitric oxide.
    Mansouri MT; Naghizadeh B; Ghorbanzadeh B; Rajabi H; Pashmforoush M
    Eur J Pharmacol; 2017 Jun; 805():84-92. PubMed ID: 28286124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in functional selectivity of morphine with the development of antinociceptive tolerance.
    Macey TA; Bobeck EN; Suchland KL; Morgan MM; Ingram SL
    Br J Pharmacol; 2015 Jan; 172(2):549-61. PubMed ID: 24666417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Deletion of Neuronal PPARγ Enhances the Emotional Response to Acute Stress and Exacerbates Anxiety: An Effect Reversed by Rescue of Amygdala PPARγ Function.
    Domi E; Uhrig S; Soverchia L; Spanagel R; Hansson AC; Barbier E; Heilig M; Ciccocioppo R; Ubaldi M
    J Neurosci; 2016 Dec; 36(50):12611-12623. PubMed ID: 27810934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NADPH-oxidase 2 activation promotes opioid-induced antinociceptive tolerance in mice.
    Doyle T; Esposito E; Bryant L; Cuzzocrea S; Salvemini D
    Neuroscience; 2013 Jun; 241():1-9. PubMed ID: 23454539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CD38, a cyclic ADP-ribosylcyclase, in morphine antinociception and tolerance.
    Hull LC; Rabender C; Gabra BH; Zhang F; Li PL; Dewey WL
    J Pharmacol Exp Ther; 2010 Sep; 334(3):1042-50. PubMed ID: 20551293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats.
    Wang YX; Gao D; Pettus M; Phillips C; Bowersox SS
    Pain; 2000 Feb; 84(2-3):271-81. PubMed ID: 10666532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of alpha 2A-adrenoceptors in morphine analgesia, tolerance and withdrawal in mice.
    Ozdogan UK; Lähdesmäki J; Hakala K; Scheinin M
    Eur J Pharmacol; 2004 Aug; 497(2):161-71. PubMed ID: 15306201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analgesic tolerance to high-efficacy agonists but not to morphine is diminished in phosphorylation-deficient S375A μ-opioid receptor knock-in mice.
    Grecksch G; Just S; Pierstorff C; Imhof AK; Glück L; Doll C; Lupp A; Becker A; Koch T; Stumm R; Höllt V; Schulz S
    J Neurosci; 2011 Sep; 31(39):13890-6. PubMed ID: 21957251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aquaporin 4 deficiency modulates morphine pharmacological actions.
    Wu N; Lu XQ; Yan HT; Su RB; Wang JF; Liu Y; Hu G; Li J
    Neurosci Lett; 2008 Dec; 448(2):221-5. PubMed ID: 18973795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of a rewarding effect and a locomotor-enhancing effect of the selective μ-opioid receptor agonist amidino-TAPA.
    Mizoguchi H; Watanabe C; Osada S; Yoshioka M; Aoki Y; Natsui S; Yonezawa A; Kanno S; Ishikawa M; Sakurada T; Sakurada S
    Psychopharmacology (Berl); 2010 Oct; 212(2):215-25. PubMed ID: 20683583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.